AAPM TG-43 formalism for brachytherapy dose calculation of a 137Cs tube source

被引:3
|
作者
Zhang, PP [1 ]
Beddar, AS
Sibata, CH
机构
[1] Columbia Univ, Dept Radiat Oncol, New York, NY 10032 USA
[2] Univ Texas, MD Anderson Canc Ctr, Dept Radiat Phys, Houston, TX 77030 USA
[3] E Carolina Univ, Dept Radiat Oncol, Greenville, NC 27858 USA
关键词
dosimetry; brachytherapy; TG-43; formalism; Monte Carlo calculations; 137Cs;
D O I
10.1118/1.1650564
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
We present a development of the use of the AAPM TG-43 dose formalism applied to Cs-137 gynecological implant sources. The geometry factor, radial dose function, and anisotropy function of a Cs-137 source modeled after the Nuclear Associates 67-809 series stainless steel jacketed tube source were derived following the AAPM TG-43 formalism. The dose rate distribution through the center of the source using the AAPM TG-43 dose formalism is calculated and compared with the calculations obtained using the Sievert summation and Monte Carlo simulation. The three methods resulted in an agreement within less than 5%, or an isodose rate line agreement within 2 mm. We demonstrate that the AAPM TG-43 formalism can be applied to Cs-137 linear sources and is capable of serving as a Cs-137 dose calculation algorithm that can be used for treatment planning purpose. (C) 2004 American Association of Physicists in Medicine.
引用
收藏
页码:755 / 759
页数:5
相关论文
共 50 条
  • [31] Developing a TG-43U1 Based Dose Calculation Treatment Planning Software for Cs-137 LDR Brachytherapy
    Sina, S.
    Faghihi, R.
    Meigooni, A.
    Siavashpour, Z.
    Mosleh-Shirazi, M.
    MEDICAL PHYSICS, 2011, 38 (06) : 3654 - U21
  • [32] Comparison of Acuros BV and TG-43 Dose Calculation for HDR Skin Brachytherapy with Flap Applicator in Heterogeneous Media
    Kang, H.
    Patel, R.
    Gros, S.
    MEDICAL PHYSICS, 2019, 46 (06) : E113 - E114
  • [33] TG-43 Parameterization of a Novel Brachytherapy Source Design of Multi-Radioisotope
    Dini, S.
    Warren, G.
    Meigooni, A.
    MEDICAL PHYSICS, 2008, 35 (06)
  • [34] Report of the Task Group 186 on model-based dose calculation methods in brachytherapy beyond the TG-43 formalism: Current status and recommendations for clinical implementation
    Beaulieu, Luc
    Tedgren, Asa Carlsson
    Carrier, Jean-Francois
    Davis, Stephen D.
    Mourtada, Firas
    Rivard, Mark J.
    Thomson, Rowan M.
    Verhaegen, Frank
    Wareing, Todd A.
    Williamson, Jeffrey F.
    MEDICAL PHYSICS, 2012, 39 (10) : 6208 - 6236
  • [35] Clinical brachytherapy with neutron emitting 252Cf sources and adherence to AAPM TG-43 dosimetry protocol
    Rivard, MJ
    Wierzbicki, JG
    Van den Heuvel, F
    Martin, RC
    McMahon, RR
    MEDICAL PHYSICS, 1999, 26 (01) : 87 - 96
  • [36] I-125 liquid in an intracranial balloon - TG-43 formalism for an extended source
    Desobry, G
    Kassaee, A
    MEDICAL PHYSICS, 2002, 29 (06) : 1220 - 1220
  • [37] Retrospective assessment of HDR brachytherapy dose calculation methods in locally advanced cervical cancer patients: AcurosBV vs. AAPM TG43 formalism
    Radcliffe, Billie Ann
    Kim, Yongbok
    Raffi, Julie
    Ayala-Peacock, Diandra N.
    Stephens, Sarah J.
    Chino, Junzo
    Meltsner, Sheridan
    Craciunescu, Oana
    JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 2025, 26 (01):
  • [38] DOSIMETRIC DIFFERENCES BETWEEN TG-43 AND MONTE CARLO CALCULATION FOR BREAST LDR BRACHYTHERAPY
    Furstoss, C.
    Bertrand, M. J.
    Poon, E.
    Reniers, B.
    Carrier, J. F.
    Pignol, J. P.
    Williamson, J.
    Beaulieu, L.
    Verhaegen, F.
    RADIOTHERAPY AND ONCOLOGY, 2008, 88 : S407 - S407
  • [39] Determination of the AAPM TG-43 Brachytherapy Dosimetry Parameters for A New Titanium-Encapsulated Yb-169 Source by Monte Carlo Calculations
    Reynoso, F.
    Munro, J.
    Cho, S.
    MEDICAL PHYSICS, 2016, 43 (06) : 3473 - 3474
  • [40] Investigation of the Influence of diferent TG-43 Ir-192 Source Functions to the Calculation of DVHs in interstitial Brachytherapy Plans
    Walke, M.
    Gademann, G.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2011, 187 : 35 - 35